It has been shown that sulforaphane, a potent agonist of Nrf2, ameliorated depression-like behavior in LPS-induced mice, decreased serum levels of TNF-α and IL-10, and inhibited activation of microglia. This evidence concerns the gene TNF and major depressive disorder.